(Q35843639)

10 August 2017

1 reference

title

Cost-effectiveness studies of pneumococcal conjugate vaccines (English)

1 reference

10 August 2017

E David G McIntosh

1

1 reference

10 August 2017

publication date

1 August 2004

1 reference

Expert Review of Vaccines

10 August 2017

published in

1 reference

10 August 2017

volume

3

1 reference

10 August 2017

issue

4

1 reference

10 August 2017

page(s)

433-442

1 reference

Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.433

Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.433

Comparative cost effectiveness of varicella, hepatitis A, and pneumococcal conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.433

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.433

Markov models in medical decision making: a practical guide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.433

Benefits and costs of immunization of children with pneumococcal conjugate vaccine in Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.433

Invasive meningococcal and pneumococcal disease in Switzerland: cost?utility analysis of different vaccine strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.433

A pharmacoeconomic evaluation of seven-valent pneumococcal conjugate vaccine in Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.433

Health economics of a hexavalent meningococcal outer-membrane vesicle vaccine in children: potential impact of introduction in the Dutch vaccination program

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.433

The cost-burden of paediatric pneumococcal disease in the UK and the potential cost-effectiveness of prevention using 7-valent pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.433

Etiology of acute lower respiratory tract infection in Central Australian Aboriginal children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.433

The cost-effectiveness of pneumococcal conjugate vaccination in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.4.433

21 January 2018

Identifiers

DOI

10.1586/14760584.3.4.433

1 reference

10 August 2017

1 reference